Navigation Links
Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Date:12/15/2008

alidated drug targets, and includes compounds being evaluated independently and with partners, including Merck & Co., Inc. and Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Arena Pharmaceuticals(R) and Arena(R) are registered service marks of the company. "APD" is an abbreviation for Arena Pharmaceuticals Development.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about APD597's development, therapeutic indication, efficacy and potential; the potential of the GDIR, including the potential to stimulate insulin release in response to increases in blood glucose; future activities under Arena's collaboration with Ortho-McNeil; the protocol, design, scope, enrollment and other aspects of the Phase 1 program for APD597; the inclusion of the evaluation of patients with type 2 diabetes in the planned clinical studies; and about Arena's strategy, internal and partnered programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, clinical trials and studies may not proceed at the time or in the manner Arena expects or at all, the results of clinical trials or preclinical studies may not be predictive of future results, Arena's ability to receive regulatory approval for its drug candidates, Arena's ability to partner lorcaserin or other of its compounds or programs, the timing, success and cost of Arena's research, out-licensing endeavors and clinical trials, Arena's ability to obtain additional financing, Arena's ability to obtain and defend its patents an
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015  China Nepstar Chain Drugstore Ltd. (NYSE: ... retail drugstore chain in China ... announced the resignation of Mr. Fuxiang Zhang ... effective immediately. Ms. Rebecca Yingnan Zhang has ... board of directors, effective immediately. Meanwhile, Ms. Zhang resigned ...
(Date:5/21/2015)... , May 21, 2015  When Ryan ... the side of his neck, he figured ... a couple weeks off from weight lifting. ... away.                               A series ... was referred to Michel Kliot, MD ...
(Date:5/21/2015)... , May 21, 2015 ... announced the addition of the "Market Assessment ... Europe" report to their offering. ,     (Logo: ... of the respiratory imaging diagnostics market in ... Europe . The service provides detailed ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4United States and Europe Respiratory Diagnostics Market Assessment 2015 2
... N.J., Feb. 1, 2011 The Board of Directors of ... has declared a quarterly dividend of 41 cents per common ... on March 10, 2011. The indicated annual dividend rate is ... a leading global medical technology company that develops, manufactures and ...
... Feb. 1, 2011 ResMed Inc. (NYSE: ...  Kieran T. Gallahue has resigned his position as Chief ... January 28, 2011.  The board has appointed Dr. Peter ... as interim Chief Executive Officer and President, effective January ...
Cached Medicine Technology:ResMed Inc. Announces Management Changes 2ResMed Inc. Announces Management Changes 3
(Date:5/24/2015)... May 25, 2015 Pacific Prime has announced that ... report looking at the cost of individual international health insurance. ... 2 looks at the cost of health insurance in six top ... on, Hong Kong , Singapore ... the UAE , the UK , Article ...
(Date:5/24/2015)... Raleigh, NC (PRWEB) May 24, 2015 ... published a paper on air quality compliance issues that ... of American workers. Surviving Mesothelioma has just posted an ... it now. , The group found airborne asbestos ... inspection data collected between 1984 and 2011. , “Asbestos ...
(Date:5/24/2015)... 2015 Medicx Media Solutions ... executive Jay Krihak as its head of programmatic ... up its expertise and leadership position in the ... Health sectors. , Krihak is an experienced, award-winning ... Krihak led sales planning teams for mobile platform ...
(Date:5/23/2015)... Newport Beach, CA (PRWEB) May 23, 2015 ... Newport Beach, California, has just posted a new article ... ear gauge repair. As Dr Benvenuti explained in ... who wear enlarged plugs in their earlobes. , Known as ... into the earlobe hole, which Dr. Benvenuti said will eventually ...
(Date:5/23/2015)... (PRWEB) May 23, 2015 A live auction ... equipment from hospitals, surgery centers and other medical facilities around ... sold including endoscopy, lab, radiology, surgery, anesthesia, exam and much ... May 27 and Thursday, May 28 starting at 9:00am CDT ... at 1400 N. 25th Avenue, Melrose Park, IL 60160. ...
Breaking Medicine News(10 mins):Health News:Pacific Prime Releases 2nd Article of Cost of Health Insurance Report 2Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Medicx Media Solutions Expands Executive Team 2Health News:Dr. Benvenuti, a Plastic Surgeon in Newport Beach, CA, Posts New Article about Repairing Ear Gauges 2Health News:Over 5,200 Lots of Medical Equipment Will Be Sold by Live Auction 2
... child in 20 will have a parent die before he or ... Father,s Day without dad on June 21. For children and families ... this time, the Highmark Caring Place, A Center for Grieving Children, ... online tools at no cost. , , "Many families celebrate ...
... Access Programs , , FRAZER, Pa., June 1 ... announced that NUVIGIL(R) (armodafinil) Tablets [C-IV], a longer-lasting formulation ... to improve wakefulness throughout the day for the millions ... treated obstructive sleep apnea, shift work sleep disorder, also ...
... ... services, recently partnered with the Arthritis Foundation to provide community outreach and education on ... from arthritis. , ... Oak Brook, IL (Vocus) June 1, 2009 -- Arthritis is one of the most ...
... mass for two years in postmenopausal women with osteopenia, ... million women in US have osteopenia, or low bone ... hip, spine and wrist(2,3)- Reclast already approved as once-yearly ... 1 Reclast (R) ...
... what is believed to be the first U.S. study designed ... researchers at the Johns Hopkins Children,s Center have found that ... an anxiety disorder among these children. , Despite its ... weekly family sessions of cognitive behavioral therapy go a long ...
... Private investigator locates California medical practice,s oldest ,test-tube baby;, Three ... reunion SAN RAMON, Calif., May 31 Elizabeth Castro Wilson, ... born in the East San Francisco Bay Area, will join ... doctors who helped create them, when the Reproductive ...
Cached Medicine News:Health News:Easing the Pain of Father's Day Without Dad, Highmark Caring Place Helps Children Cope With the Death of a Parent 2Health News:Easing the Pain of Father's Day Without Dad, Highmark Caring Place Helps Children Cope With the Death of a Parent 3Health News:Cephalon Announces the Availability of NUVIGIL for the Treatment of Excessive Sleepiness Associated with Treated Obstructive Sleep Apnea, Shift Work Disorder and Narcolepsy 2Health News:Cephalon Announces the Availability of NUVIGIL for the Treatment of Excessive Sleepiness Associated with Treated Obstructive Sleep Apnea, Shift Work Disorder and Narcolepsy 3Health News:Cephalon Announces the Availability of NUVIGIL for the Treatment of Excessive Sleepiness Associated with Treated Obstructive Sleep Apnea, Shift Work Disorder and Narcolepsy 4Health News:Cephalon Announces the Availability of NUVIGIL for the Treatment of Excessive Sleepiness Associated with Treated Obstructive Sleep Apnea, Shift Work Disorder and Narcolepsy 5Health News:AthletiCo Physical Therapy Partners with Arthritis Foundation 2Health News:AthletiCo Physical Therapy Partners with Arthritis Foundation 3Health News:FDA Approves Reclast(R) to Prevent Osteoporosis in Postmenopausal Women With Convenient Less Frequent Dosing 2Health News:FDA Approves Reclast(R) to Prevent Osteoporosis in Postmenopausal Women With Convenient Less Frequent Dosing 3Health News:FDA Approves Reclast(R) to Prevent Osteoporosis in Postmenopausal Women With Convenient Less Frequent Dosing 4Health News:FDA Approves Reclast(R) to Prevent Osteoporosis in Postmenopausal Women With Convenient Less Frequent Dosing 5Health News:FDA Approves Reclast(R) to Prevent Osteoporosis in Postmenopausal Women With Convenient Less Frequent Dosing 6Health News:Hopkins study: When adult patients have anxiety disorder, their children need help too 2Health News:Found: First IVF Baby Born in East Bay 25 Years Ago 2
... facilitates real time information collection. It ... first module is a software link ... the database where information is captured ... the user interface, which allows access ...
... provides a solution for instantaneously locating ... or unauthorized movement of patients or ... key concern. Certain patients, such as ... patients with highly communicable diseases, patients ...
... PDC Smart™ Labels have a direct ... Texas Instruments Tag-it™ HF-I transponder. When ... codes, text and other graphics may ... variable data is programmed to the ...
PDC RFID Smart™ Cards can be printed and programmed using a dye-sublimation card printer & programmer....
Medicine Products: